How much funding has Deep Genomics raised?

Deep Genomics has raised $236.7M in total funding, most recently a Series C round.

Who are Deep Genomics's investors?

Deep Genomics's investors include Khosla Ventures, SoftBank, Future Ventures, True Ventures, Amplitude Ventures, Magnetic.

When was Deep Genomics founded?

Deep Genomics was founded in 2015.

Where is Deep Genomics headquartered?

Deep Genomics is headquartered in Toronto, Ontario, Canada.

What industry is Deep Genomics in?

Deep Genomics operates in Artificial Intelligence, Biotech, Healthcare.

How many employees does Deep Genomics have?

Deep Genomics has 51-200 employees.

Deep Genomics

Revolutions in AI, RNA biology and automation

Toronto, Canada · Founded 2015 · $236.7M raised

Artificial Intelligence

Biotech

Healthcare

Headquarters: Toronto, Ontario
Employees: 51–200
Founded: 2015
Business Model: B2B

Website: deepgenomics.com
Total Funding: $236.7M
Last Round: $180.0M Series CJul 2021
Rounds: 4

About

Deep Genomics is a Toronto-based biotechnology company at the forefront of AI-powered drug discovery. Founded in 2015 by Brendan Frey, a professor at the University of Toronto and co-founder of the Vector Institute for Artificial Intelligence, the company has built proprietary AI platforms that untangle the complexity of RNA biology to identify novel therapeutic targets and evaluate thousands of drug candidates. Deep Genomics' technology suite includes BigRNA, the world's first AI foundation model for RNA biology, and its successor BigRNA+, which expands target identification into complex genetic diseases. The interdisciplinary team of 100+ experts spans artificial intelligence, molecular biology, machine learning, organic chemistry, and clinical development. The company has deep scientific advisory relationships with Yann LeCun and other leading researchers.

Summary

Deep Genomics is an Artificial Intelligence company based in Toronto, Canada, founded in 2015. It has raised $236.7M in total across 4 rounds, most recently a $180.0M Series C round in Jul 2021. Investors include Khosla Ventures, SoftBank and Future Ventures.